Document Detail

Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis.
MedLine Citation:
PMID:  21989829     Owner:  NLM     Status:  MEDLINE    
IN CONCLUSION: Bone marrow MSCs transplantation either undifferentiated or differentiated can be used as a potential treatment for liver cirrhosis.
Mervat El-Ansary; Iman Abdel-Aziz; Sherif Mogawer; Samah Abdel-Hamid; Olfat Hammam; Salwa Teaema; Marwa Wahdan
Related Documents :
10445609 - Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoido...
17127809 - Prognostic role of alveolar-arterial oxygen pressure difference in acute pulmonary embo...
14974659 - Pediatric empyema--an algorithm for early thoracoscopic intervention.
10782709 - Pyogenic lung infections: factors for predicting clinical outcome of lung abscess and t...
908209 - Prospective evaluation for pneumonectomy using the 99mtechnetium quantitative perfusion...
18724219 - Lung transplantation for lymphangioleiomyomatosis: the french experience.
24695919 - Revision total knee arthroplasty in the young patient: is there trouble on the horizon?
22854999 - Reconstructive surgery for overcorrected clubfoot in adults.
22142459 - Long-term results of breast conservation and immediate volume replacement with myocutan...
Publication Detail:
Type:  Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Stem cell reviews     Volume:  8     ISSN:  1558-6804     ISO Abbreviation:  Stem Cell Rev     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-06     Completed Date:  2012-12-17     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  101255952     Medline TA:  Stem Cell Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  972-81     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, CD29 / metabolism
Cell Differentiation
Cells, Cultured
Hepatitis C, Chronic / complications*,  virology
Liver Cirrhosis / therapy*,  virology
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stromal Cells / metabolism,  physiology*
Middle Aged
Nerve Tissue Proteins / metabolism
Receptors, Nerve Growth Factor / metabolism
Transplantation, Autologous
Treatment Outcome
Reg. No./Substance:
0/Antigens, CD29; 0/NGFR protein, human; 0/Nerve Tissue Proteins; 0/Receptors, Nerve Growth Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Change in treatment strategy for intracranial germinoma: long-term follow-up experience at a single ...
Next Document:  In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in ...